NEWS:
Interview "From Vision To Reality"
Business Enquirer Magazine with AUTOMA+ Special Feature
November 05, 2025
Explore the stories spotlighting innovation, people‑centered leadership, and the year’s most influential automation and digital transformation event. In a concise Q&A interview Dr. Ewa Gajewska— shows how SYNTHIA expert‑coded retrosynthesis accelerates route design, enables greener choices, and streamlines team collaboration from idea to executable pathways. Starting from page 160.
Dr. Ewa Gajewska, Head of Product Management for SYNTHIA® Retrosynthesis Software at Merck KGaA, Darmstadt, Germany, leads the development of our computer‑assisted synthetic planning platform — bringing together expert‑coded rules to help chemists design practical routes from commercially available building blocks.
Looking ahead to AUTOMA+ 2025: the Pharmaceutical Automation and Digitalisation Congress heads to Vösendorf, Austria, on November 24–25 for its 5th anniversary edition.
This year’s congress partners include Merck KGaA Darmstadt Germany, alongside ESTEVE, Octapharma, GSK, Boehringer Ingelheim Pharma, and the European Union Agency for the Space Programme — underscoring a strong focus on digital maturity and innovation at scale.
Expect deep dives into AI‑enabled R&D, digital manufacturing and twins, smart supply chains, sustainability, data privacy, and patient‑centric use of digital tools.
If you’re attending AUTOMA+, connect with us to learn how chemists are using SYNTHIA to speed route scouting while improving sustainability. From expert‑coded transformations and buyable‑building‑block strategies to API‑driven SAS scoring of large libraries, we’ll be ready to walk through practical use cases and quick wins for your pipeline.
